Drug Screening Systems, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 8
What Drug Screening Systems, Inc. makes
Drug Screening Systems, Inc. manufactures the MicroLine Screen line of immunoassay test devices for detecting specific drugs of abuse in biological samples. These include tests for cannabinoid, cocaine, barbiturates, amphetamine, opiates, methamphetamine, benzodiazepine, and phencyclidine.
The MicroLine Screen devices are classified as Class II medical devices and are listed in the FDA 510(k) registry. The company is based in the United States.
Catalogue
Microline Screen For Cannabinoid Ref K914915
510(k) 510(k)Mircoline Screen For Cocaine Ref K911652
510(k) 510(k)Microline Screen For Barbiturates Ref K933480
510(k) 510(k)Microline Screen For Amphetamine Ref K935052
510(k) 510(k)Microline Screen For Opiates Ref K905491
510(k) 510(k)Microline Screen For Methamphetamine Ref K910525
510(k) 510(k)Microline Screen For Benzodiazepine Ref K945829
510(k) 510(k)Microline Screen For Phencyclidine Ref K921651
510(k) 510(k)
Frequently asked questions
How many devices does Drug Screening Systems, Inc. have in the registry?
The registry currently lists 8 devices for Drug Screening Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Drug Screening Systems, Inc.'s devices?
Among its 8 most recently registered devices, Drug Screening Systems, Inc. has devices listed in FDA 510(k) (8 devices).
What risk classes do Drug Screening Systems, Inc.'s devices fall under?
Among its 8 most recently registered devices, the classes recorded for Drug Screening Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Drug Screening Systems, Inc. in the registry?
The most recently registered devices listed for Drug Screening Systems, Inc. include MICROLINE SCREEN FOR CANNABINOID, MIRCOLINE SCREEN FOR COCAINE, MICROLINE SCREEN FOR BARBITURATES and MICROLINE SCREEN FOR AMPHETAMINE.